Skip to main content

Table 1 Statistically significant (|ES|> ES Error and p < 0.05) metabolite variations observed in the polar metabolome of MDA-MB-231/R (R) compared to MDA-MB-231 (S) (not considering time-course evolution)

From: Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics

Metabolite

δH (multiplicity)

R vs. S

ES ± Error

p-value

Amino acids and derivatives

Cr

3.04 (s)

0.9 ± 0.6

1.5 × 10–3

GSH

2.96 (m)

3.8 ± 0.9

2.2 × 10–18

Gln

2.45 (m)

2.8 ± 0.8

2.1 × 10–13

Glu

2.36 (m)

−3.4 ± 0.8

5.6 × 10–15

Gly

3.55 (s)

0.6 ± 0.5

4.9 × 10–2

Ile

0.94 (t)

1.4 ± 0.6

5.5 × 10–6

Lys

1.73 (m)

−1.2 ± 0.6

1.3 × 10–4

Met †

2.64 (t)

2.6 ± 0.7

1.3 × 10–8

PCr

3.05 (s)

2.2 ± 0.7

3.1 × 10–10

Phe

7.33 (m)

−0.7 ± 0.6

1.8 × 10–2

Pro

1.98 (m)

−0.9 ± 0.6

1.2 × 10–2

Sarcosine

2.76 (s)

0.9 ± 0.6

1.5 × 10–3

Tau

3.43 (t)

2.4 ± 0.7

1.2 × 10–11

Val

1.05 (d)

0.8 ± 0.6

3.8 × 10–3

Choline compounds

Cho

3.20 (s)

−1.7 ± 0.6

1.5 × 10–7

GPC

3.23 (s)

−2.3 ± 0.7

2.3 × 10–6

Nucleotides and related metabolites

Adenine

8.19 (s)

−2.9 ± 0.8

1.5 × 10–12

Ado

8.27 (s)

−3.0 ± 0.8

3.0 × 10–10

ADP

8.54 (s)

−0.8 ± 0.6

1.5 × 10–2

AMP

8.61 (s)

−1.7 ± 0.6

2.5 × 10–8

HX

8.20 (s)

−1.9 ± 0.7

7.6 × 10–9

IMP

8.58 (s)

−2.0 ± 0.7

2.3 × 10–7

Ino, Ado

8.35 (s)

−1.3 ± 0.6

8.4 × 10–5

NAD+

8.43 (s)

−3.4 ± 0.8

3.8 × 10–10

Pseudouridine

7.68 (s)

−0.9 ± 0.6

1.5 × 10–3

UDP

8.01 (d)

−1.0 ± 0.6

1.3 × 10–4

UDP-GlcNAc

5.52 (dd)

−1.2 ± 0.6

4.4 × 10–5

UDP-Glc/GlcA

7.95 (d)

−3.2 ± 0.8

3.2 × 10–14

UMP

8.11 (s)

−2.1 ± 0.7

2.4 × 10–9

Uracil

5.81 (d)

−0.9 ± 0.6

3.3 × 10–3

Uridine

7.88 (d)

−1.2 ± 0.6

6.8 × 10–5

Organic acids

Acetate

1.92 (s)

−1.6 ± 0.6

1.2 × 10–6

Formate

8.46 (s)

−0.6 ± 0.5

4.0 × 10–2

Fumarate

6.52 (s)

−2.0 ± 0.7

3.4 × 10–9

Lactate

4.10 (q)

−1.0 ± 0.6

6.1 × 10–4

PA

0.90 (s)

−1.4 ± 0.6

8.8 × 10–6

Other compounds

DMA

2.73 (s)

2.6 ± 0.7

2.5 × 10–8

Myo-Inositol

4.06 (t)

−1.3 ± 0.6

8.4 × 10–4

  1. All metabolites remain statistically significant (p < 0.05) after False Discovery Rate (FDR) correction
  2. 3-letter code for amino acids; Ado adenosine, DMA dimethylamine, IMP inosine monophosphate, Ino inosine, PA pantothenate, PCr phosphocreatine, UDP uridine diphosphate, UMP uridine monophosphate; other abbreviations as defined in the caption of Fig. 2
  3. Metabolites in bold and underlined show more marked differences in levels (p ≤ 10–10 and |ES|≥ 2.0)
  4. †Tentative assignment